Welcome to LookChem.com Sign In|Join Free
  • or
1,3-Benzenedicarboxylic acid, 5-bromo-4-hydroxy-, 1-methyl ester is a complex organic compound with the chemical formula C10H9BrO6. It is a derivative of 1,3-benzenedicarboxylic acid, featuring a bromine atom at the 5th position, a hydroxyl group at the 4th position, and a methyl ester group at the 1st position. 1,3-Benzenedicarboxylic acid, 5-bromo-4-hydroxy-, 1-methyl ester is characterized by its unique structure, which includes a benzene ring with two carboxyl groups at the 1st and 3rd positions, a bromine atom at the 5th position, and a hydroxyl group at the 4th position. The 1-methyl ester group further modifies the molecule's properties, making it a potentially useful intermediate in the synthesis of various pharmaceuticals, dyes, and other specialty chemicals. Due to its specific functional groups and structural features, 1,3-Benzenedicarboxylic acid, 5-bromo-4-hydroxy-, 1-methyl ester may exhibit unique reactivity and properties that can be exploited in various chemical transformations and applications.

95088-64-5

Post Buying Request

95088-64-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

95088-64-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 95088-64-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,5,0,8 and 8 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 95088-64:
(7*9)+(6*5)+(5*0)+(4*8)+(3*8)+(2*6)+(1*4)=165
165 % 10 = 5
So 95088-64-5 is a valid CAS Registry Number.

95088-64-5Relevant academic research and scientific papers

Electrostatic effects in acylation of hemoglobin by aspirins

Massil,Shi,Klotz

, p. 1851 - 1853 (1984)

Carboxylate substituents added to the salicylate ring increase the effectiveness of a variety of aspirins and diaspirins in acylating hemoglobin. Even more effective are a series of monoesters of dicarboxylate derivatives. Bis(5-carbomethoxysalicyl)fumarate and -succinate at 5 mM concentrations modify ~100% of the hemoglobin in solution and should alter the aggregation behavior of sickle hemoglobin.

COMPOUNDS CONTAINING FUSED RINGS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF

-

, (2011/11/01)

The invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating Alzheimer's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 95088-64-5